ArthroCare’s SpineWand Casts Spell On Investors In October; Stock Up 26%
This article was originally published in The Gray Sheet
Executive Summary
ArthroCare's move into the $175 mil. vertebral compression fracture market through the acquisition of Parallax and the launch of Cavity SpineWand spirited investors in October, lifting the firm's shares 26%